Literature DB >> 15517263

The basis for splenic segmental dearterialization: a post-mortem study.

D Ignjatovic1, B Stimec, V Zivanovic.   

Abstract

The anatomical features of splenic segmental vessels in 102 human spleen autopsy specimens were analyzed. Methods applied were corrosion casting and post-mortem arteriography. The superior terminal splenic branch divided extracapsularly into 2.8+/-0.9 (range 2-5) and the inferior terminal splenic branch into 2.3+/-0.75 (range 2-5) branches per sample. The extracapsular lengths of the segmental branches ranged from 4.0 to 16.7 mm and the calibers from 0.4 to 2.2 mm. Superior polar arteries occurred in 31.3% and inferior polar arteries in 20.6% of cases. Their average extracapsular lengths were 39 mm and 31 mm, respectively. In conclusion, segmental splenic arteries have an extrasplenic origin and course, with an average length and caliber that allow surgical access and ligation, in order to achieve segmental dearterialization for hemostasis purposes and splenic preservation.

Entities:  

Mesh:

Year:  2004        PMID: 15517263     DOI: 10.1007/s00276-004-0279-2

Source DB:  PubMed          Journal:  Surg Radiol Anat        ISSN: 0930-1038            Impact factor:   1.246


  15 in total

1.  Evaluation of splenic circulation after spleen-preserving distal pancreatectomy by dividing the splenic artery and vein.

Authors:  Y Sato; S Shimoda; N Takeda; N Tanaka; K Hatakeyama
Journal:  Dig Surg       Date:  2000       Impact factor: 2.588

2.  The incidence of splenectomy is decreasing: lessons learned from trauma experience.

Authors:  A T Rose; M I Newman; J Debelak; C W Pinson; J A Morris; D D Harley; W C Chapman
Journal:  Am Surg       Date:  2000-05       Impact factor: 0.688

3.  Anatomoclinical significance of splenic artery anastomotic bridges.

Authors:  D Ignjatović; B Stimec; B Durić; M Milićević
Journal:  Acta Chir Iugosl       Date:  2000

4.  Anatomic basis for conservative surgery of the spleen.

Authors:  M L Sow; A Dia; T Ouedraogo
Journal:  Surg Radiol Anat       Date:  1991       Impact factor: 1.246

5.  Splenic studies. I. Susceptibility to infection after splenectomy performed in infancy.

Authors:  H KING; H B SHUMACKER
Journal:  Ann Surg       Date:  1952-08       Impact factor: 12.969

6.  [Study of the vascular segmentation of the spleen].

Authors:  P Cougard; P Trouilloud; B Morizot; M C Gelle; J M Autissier
Journal:  Bull Assoc Anat (Nancy)       Date:  1984-03

7.  Is splenic lobe/segment dearterialization feasible for inferior pole trauma during left hemicolectomy?

Authors:  D Ignjatovic; B Djuric; V Zivanovic
Journal:  Tech Coloproctol       Date:  2001-04       Impact factor: 3.781

8.  Splenic infarction complicating ligation of a gastroduodenal artery aneurysm.

Authors:  W Schweizer; N C Gries; G Maddern; J Triller
Journal:  Dig Surg       Date:  1999       Impact factor: 2.588

9.  Partial dearterialization of the spleen in thalassemia major.

Authors:  S A Banani
Journal:  J Pediatr Surg       Date:  1998-03       Impact factor: 2.545

Review 10.  Iatrogenic splenic injury.

Authors:  K Cassar; A Munro
Journal:  J R Coll Surg Edinb       Date:  2002-12
View more
  3 in total

Review 1.  A systematic review of splenic artery variants based on cadaveric studies.

Authors:  Dimitrios K Manatakis; Maria Piagkou; Marios Loukas; John Tsiaoussis; Spiridon G Delis; Ioannis Antonopoulos; Dimitrios Chytas; Konstantinos Natsis
Journal:  Surg Radiol Anat       Date:  2021-01-22       Impact factor: 1.246

2.  Control of splenic bleeding during splenic flexure mobilisation by devascularisation of the inferior pole of the spleen.

Authors:  J O Larkin; P A Carroll; P H McCormick; B J Mehigan
Journal:  Tech Coloproctol       Date:  2012-05-16       Impact factor: 3.781

3.  Treatment of hemangioma of the spleen by preoperative partial splenic embolization plus laparoscopic partial splenectomy: A case report.

Authors:  Lu Zheng; Changlin Deng; Jing Li; Liang Wang; Nan You; Ke Wu; Weiwei Wang
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.